Purinergic P2Y6 receptors: a new therapeutic target of age-dependent hypertension

C Sunggip, A Nishimura, K Shimoda… - Pharmacological …, 2017 - Elsevier
Aging has a remarkable effect on cardiovascular homeostasis and it is known as the major
non-modifiable risk factor in the development of hypertension. Medications targeting …

Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II–induced hypertension

A Nishimura, C Sunggip, H Tozaki-Saitoh… - Science …, 2016 - science.org
The angiotensin (Ang) type 1 receptor (AT1R) promotes functional and structural integrity of
the arterial wall to contribute to vascular homeostasis, but this receptor also promotes …

Purinergic P2Y receptors: Molecular diversity and implications for treatment of cardiovascular diseases

A Nishimura, C Sunggip, S Oda… - Pharmacology & …, 2017 - Elsevier
Purinergic signaling, mediated mainly by G protein-coupled P2Y receptors (P2YRs), is now
attracting attention as a new therapeutic target for preventing or treating cardiovascular …

The role of P2Y6R in cardiovascular diseases and recent development of P2Y6R antagonists

M Zhou, W Wang, Y Li, Q Zhang, H Ji, H Li, Q Hu - Drug Discovery Today, 2020 - Elsevier
Highlights•Distribution and function of P2Y 6 R.•P2Y 6 R participated in pathogenesis of
atherosclerosis and other cardiovascular diseases.•The development of P2Y 6 R …

Purinoceptor: a novel target for hypertension

X Li, L Zhu, J Lv, X Cao - Purinergic Signalling, 2023 - Springer
Hypertension is the leading cause of morbidity and mortality globally among all
cardiovascular diseases. Purinergic signalling plays a crucial role in hypertension through …

Purinergic receptors and atherosclerosis: emerging role for vessel wall P2Y12

BH Rauch, JG Filep - Cardiovascular Research, 2014 - academic.oup.com
Platelets play a key role in primary haemostasis and also represent an important interface
between thrombosis, immunity, and atherogenesis. 1 Platelet-triggered inflammatory …

Purinergic P2Y2 receptors modulate endothelial sprouting

S Mühleder, C Fuchs, J Basílio, D Szwarc, K Pill… - Cellular and Molecular …, 2020 - Springer
Purinergic P2 receptors are critical regulators of several functions within the vascular
system, including platelet aggregation, vascular inflammation, and vascular tone. However …

P2Y2 receptor activation decreases blood pressure and increases renal Na+ excretion

T Rieg, M Gerasimova, JL Boyer… - American Journal of …, 2011 - journals.physiology.org
ATP and UTP are endogenous agonists of P2Y2/4 receptors. To define the in vivo effects of
P2Y2 receptor activation on blood pressure and urinary excretion, we compared the …

P2Y6 Receptor Potentiates Pro-Inflammatory Responses in Macrophages and Exhibits Differential Roles in Atherosclerotic Lesion Development

RA Garcia, M Yan, D Search, R Zhang, NL Carson… - PloS one, 2014 - journals.plos.org
Background P2Y6, a purinergic receptor for UDP, is enriched in atherosclerotic lesions and
is implicated in pro-inflammatory responses of key vascular cell types and macrophages …

More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease

B Wernly, Z Zhou - American Journal of Physiology-Heart …, 2020 - journals.physiology.org
Cardiovascular disease is a major cause of morbidity and mortality worldwide. Innovative
new treatment options for this cardiovascular pandemic are urgently needed. Activation of …